Skip to main content
. 2016 Dec 9;11(12):e0167413. doi: 10.1371/journal.pone.0167413

Table 1. Baseline characteristics by 30-day hospital readmission status.

Variable All patients (n = 74102) Readmitted patients (n = 11492) No readmitted patients (n = 62610) p-value
Patient Demographics
Age, Mean (SD) 61.27 (17.18) 65.27 (15.57) 60.53 (17.36) <0.001
Gender, Male (%) 38641 (52.1%) 6374 (55.5%) 32267 (51.5%) <0.001
Ethnicity
Chinese (%) 54162 (73.1%) 8667 (75.4%) 45495 (72.7%) <0.001
Indian (%) 7184 (9.7%) 1091 (9.5%) 6093 (9.7%) 0.438
Malay (%) 9200 (12.4%) 1387 (12.1%) 7813 (12.5%) 0.227
Others (%) 3556 (4.8%) 347 (3%) 3209 (5.1%) <0.001
Required financial assistance using Medifund (%) 1907 (2.6%) 636 (5.5%) 1271 (2%) <0.001
Past Healthcare Utilization
ED visits (6 month before index admission), Mean (SD) 1.02 (2.25) 2.48 (4.24) 0.75 (1.49) <0.001
Specialist Clinic visits (1 year before index admission), Mean (SD) 3.93 (9.19) 6.93 (15.24) 3.37 (7.43) <0.001
Hospital admissions (1 year before index admission), Mean (SD) 1.58 (3.14) 4.01 (5.88) 1.13 (2.02) <0.001
Index Admission Variables
Index admission was urgent (%) 57017 (76.9%) 9763 (85%) 47254 (75.5%) <0.001
Index admission was planned (%) 13471 (18.2%) 1325 (11.5%) 12146 (19.4%) <0.001
Stayed in a subsidized ward during index admission (%) 60463 (81.6%) 10286 (89.5%) 50177 (80.1%) <0.001
Required second line antibiotics during index admission (%) 5312 (7.2%) 826 (7.2%) 4486 (7.2%) 0.947
Required inpatient dialysis during index admission (%) 4861 (6.6%) 1233 (10.7%) 3628 (5.8%) <0.001
Required intravenous Furosemide 40mg and above during index admission (%) 5826 (7.9%) 1268 (11%) 4558 (7.3%) <0.001
Required isolation during index admission (%) 1422 (1.9%) 300 (2.6%) 1122 (1.8%) <0.001
Length of stay of index admission, Mean (SD) 6.09 (10.37) 5.29 (5.38) 6.23 (11.04) <0.001
Medical Comorbidities (ICD codes past 7 years)
Depression (%) 11554 (15.6%) 3396 (29.6%) 8158 (13%) <0.001
Stroke (%) 955 (1.3%) 146 (1.3%) 809 (1.3%) 0.885
Metastatic Disease (%) 7543 (10.2%) 1244 (10.8%) 6299 (10.1%) 0.013
Non-metastatic malignancy (%) 11810 (15.9%) 1895 (16.5%) 9915 (15.8%) 0.081
Peripheral Vascular Disease (%) 2484 (3.4%) 416 (3.6%) 2068 (3.3%) 0.088
Heart Failure or Fluid Overload (%) 7864 (10.6%) 1236 (10.8%) 6628 (10.6%) 0.6
Pressure Ulcer (%) 1907 (2.6%) 312 (2.7%) 1595 (2.5%) 0.313
Thromboembolism (%) 3896 (5.3%) 628 (5.5%) 3268 (5.2%) 0.29
Spine Fracture (%) 1718 (2.3%) 298 (2.6%) 1420 (2.3%) 0.036
Coronary Heart Disease or Myocardial Infarction (%) 8922 (12%) 1454 (12.7%) 7468 (11.9%) 0.029
Hip Fracture (%) 1199 (1.6%) 185 (1.6%) 1014 (1.6%) 0.971
Atrial Fibrillation (%) 4378 (5.9%) 675 (5.9%) 3703 (5.9%) 0.882
Epilepsy (%) 788 (1.1%) 131 (1.1%) 657 (1%) 0.412
Parkinsonism (%) 840 (1.1%) 123 (1.1%) 717 (1.1%) 0.516
Anxiety (%) 734 (1%) 132 (1.1%) 602 (1%) 0.07
Bipolar Disorder (%) 178 (0.2%) 33 (0.3%) 145 (0.2%) 0.31
Collagen Vascular Disease (%) 1152 (1.6%) 179 (1.6%) 973 (1.6%) 1
Dementia (%) 1840 (2.5%) 256 (2.2%) 1584 (2.5%) 0.06
Hypothyroidism (%) 1323 (1.8%) 216 (1.9%) 1107 (1.8%) 0.429
Chronic Kidney Disease, Stages 1–4 (%) 11266 (15.2%) 1804 (15.7%) 9462 (15.1%) 0.111
Chronic Obstructive Pulmonary Disease (%) 1589 (2.1%) 248 (2.2%) 1341 (2.1%) 0.94
Osteoarthritis (%) 4947 (6.7%) 821 (7.1%) 4126 (6.6%) 0.03
Benign Prostatic Hypertrophy (%) 2651 (3.6%) 382 (3.3%) 2269 (3.6%) 0.118
Asthma (%) 2186 (2.9%) 321 (2.8%) 1865 (3%) 0.294
Hyperlipidemia (%) 17722 (23.9%) 2851 (24.8%) 14871 (23.8%) 0.015
Hypertension (%) 24835 (33.5%) 3925 (34.2%) 20910 (33.4%) 0.117
Chronic Kidney Disease Stage 5 or End Stage Renal Failure (%) 8866(12%) 1441(12.5%) 7425 (11.9%) 0.04
Diabetes (%) 16201 (21.9%) 2614 (22.7%) 13587 (21.7%) 0.013
History of Alcoholism (%) 1372 (1.9%) 316 (2.7%) 1056 (1.7%) <0.001
Charlson Comorbidity Index, Mean (SD) 2.27 (2.85) 3.83 (3.15) 1.98 (2.69) <0.001